About Infection Control and Biosafety Products
Infection control products are germicides used by hospitals, research centers, and commercial and domestic users to prevent the spread of infections within the healthcare setting. Biosafety products are used to protect individuals in research laboratories, healthcare facilities, and other places from various infections and hazardous effect of chemicals and microorganisms.
Technavio’s analysts forecast the global infection control and biosafety products market to grow at a CAGR of 4.21% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global infection control and biosafety products market for 2017-2021. To calculate the market size, the report considers the sales of infection control and biosafety products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Infection Control and Biosafety Products Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• 3M
• Reckitt Benckiser
• BODE Chemie
• STERIS
• Thermo Fisher Scientific
Other prominent vendors
• ABC Compounding
• American Biotech Labs
• Baxter
• Bio-Cide International
• CareFusion (BD)
• Ecolab
• HEMCO Corporation
• Kewaunee
• Labconco
• Metrex Research
• The Baker Company
• The Clorox Company
• Terra Universal
Market driver
• Outbreak of life-threatening diseases
• For a full, detailed list, view our report
Market challenge
• Stringent regulatory policies
• For a full, detailed list, view our report
Market trend
• Increased awareness of sanitation and hygiene
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by products
• Market overview
• Global infection control products market
• Global biosafety products market
PART 07: Geographical segmentation
• Market overview
• Infection control and biosafety products market in Americas
• Infection control and biosafety products market in EMEA
• Infection control and biosafety products market in APAC
PART 08: Market segmentation by end-user
• Market overview
• Global infection control and biosafety products by healthcare and research laboratories
• Global infection control and biosafety products market by domestic and commercial users
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Increased awareness of sanitation and hygiene
• Growing number of end-users
• Increased availability of products
• Growth of emerging markets
• Rise in older population
PART 12: Vendor landscape
• Competitive landscape
PART 13: Key vendor analysis
• 3M
• Reckitt Benckiser
• BODE Chemie
• STERIS
• Thermo Fisher Scientific
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Overview of global infection control and biosafety products market from stakeholder's perspective
Exhibit 02: Key factors impacting growth of global infection control and biosafety products market
Exhibit 03: Global infection control and biosafety products market segmentation by products
Exhibit 04: Segmentation of infection control products
Exhibit 05: Classification of disinfectants based on their level of impact
Exhibit 06: Segmentation of biosafety products
Exhibit 07: Global infection control and biosafety products market 2016-2021 ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Global infection control and biosafety products market by product type 2016-2021
Exhibit 10: Global infection control products market 2016-2021 ($ billions)
Exhibit 11: Global biosafety products market 2016-2021 ($ billions)
Exhibit 12: Global infection control and biosafety products market by geography
Exhibit 13: Global infection control and biosafety products market by geography 2016-2021 (% share)
Exhibit 14: Infection control and biosafety products market in Americas 2016-2021 ($ billions)
Exhibit 15: Infection control and biosafety products market in EMEA 2016-2021 ($ billions)
Exhibit 16: Aging population growth in major countries in EMEA (% of population)
Exhibit 17: Infection control and biosafety products market in APAC 2016-2021 ($ billions)
Exhibit 18: Global infection control and biosafety products market by end-users 2016-2021 (% share)
Exhibit 19: Sources of acquired infection by hospitals and research laboratories
Exhibit 20: Global infection control and biosafety products market by healthcare and research laboratories 2016-2021 ($ billions)
Exhibit 21: Sources of acquired infection by domestic and commercial users
Exhibit 22: Global infection control and biosafety products market by domestic and commercial users 2016-2021 ($ billions)
Exhibit 23: Average annual per capita growth rate (AAGR) in healthcare spending vs. GDP of countries 2009-2013 (%)
Exhibit 24: Percentage of rural and urban population using sanitation facilities in different geographic locations 2015
Exhibit 25: Growth opportunities of different research areas in life science and related research
Exhibit 26:M: Profile
Exhibit 27:M: Strength analysis
Exhibit 28:M: Strategy assessment
Exhibit 29:M: Opportunity assessment
Exhibit 30: Reckitt Benckiser: Profile
Exhibit 31: Reckitt Benckiser: Strength analysis
Exhibit 32: Reckitt Benckiser: Strategy assessment
Exhibit 33: Reckitt Benckiser: Opportunity assessment
Exhibit 34: BODE Chemie: Profile
Exhibit 35: BODE Chemie: Strength analysis
Exhibit 36: BODE Chemie: Strategy assessment
Exhibit 37: BODE Chemie: Opportunity assessment
Exhibit 38: STERIS: Profile
Exhibit 39: STERIS: Strength analysis
Exhibit 40: STERIS: Strategy assessment
Exhibit 41: STERIS: Opportunity assessment
Exhibit 42: Thermo Fisher Scientific: Profile
Exhibit 43: Thermo Fisher Scientific: Strength analysis
Exhibit 44: Thermo Fisher Scientific: Strategy assessment
Exhibit 45: Thermo Fisher Scientific: Opportunity assessment
